Cargando…
PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429756/ http://dx.doi.org/10.1097/01.HS9.0000975916.71832.73 |
| _version_ | 1785090791571456000 |
|---|---|
| author | Shin, Junghoon Lee, Ji Yun Lee, Gyeong-Won Kim, Won Seog Park, Yong Do, Young Rok Kim, Dae Sik Kim, Ki Hwan Choi, Yoon Seok Koh, Youngil |
| author_facet | Shin, Junghoon Lee, Ji Yun Lee, Gyeong-Won Kim, Won Seog Park, Yong Do, Young Rok Kim, Dae Sik Kim, Ki Hwan Choi, Yoon Seok Koh, Youngil |
| author_sort | Shin, Junghoon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429756 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104297562023-08-17 PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA Shin, Junghoon Lee, Ji Yun Lee, Gyeong-Won Kim, Won Seog Park, Yong Do, Young Rok Kim, Dae Sik Kim, Ki Hwan Choi, Yoon Seok Koh, Youngil Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429756/ http://dx.doi.org/10.1097/01.HS9.0000975916.71832.73 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Shin, Junghoon Lee, Ji Yun Lee, Gyeong-Won Kim, Won Seog Park, Yong Do, Young Rok Kim, Dae Sik Kim, Ki Hwan Choi, Yoon Seok Koh, Youngil PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA |
| title | PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA |
| title_full | PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA |
| title_fullStr | PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA |
| title_full_unstemmed | PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA |
| title_short | PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA |
| title_sort | pb2297: phase ii study of bortezomib, cytarabine, and dexamethasone in relapsed or refractory mantle cell lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429756/ http://dx.doi.org/10.1097/01.HS9.0000975916.71832.73 |
| work_keys_str_mv | AT shinjunghoon pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT leejiyun pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT leegyeongwon pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT kimwonseog pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT parkyong pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT doyoungrok pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT kimdaesik pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT kimkihwan pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT choiyoonseok pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma AT kohyoungil pb2297phaseiistudyofbortezomibcytarabineanddexamethasoneinrelapsedorrefractorymantlecelllymphoma |